Advisory Research Inc Omnicell, Inc Transaction History

Advisory Research Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 17, 2022	BUY	$105.64 - $129.11 $382,522 - $467,507	3,621 New	3,621 $412,000
Q1 2022 May 16, 2022	SELL	$120.68 - $180.51 $905,582 - $1.35 Million	-7,504 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$153.26 - $183.62 $47,817 - $57,289	-312 Reduced 3.99%	7,504 $1.35 Million
Q3 2021 Nov 12, 2021	SELL	$141.84 - $160.88 $103,968 - $117,925	-733 Reduced 8.57%	7,816 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $151.45 $360,370 - $420,122	2,774 Added 48.03%	8,549 $1.3 Million
Q1 2021 May 12, 2021	BUY	$117.78 - $143.9 $680,179 - $831,022	5,775 New	5,775 $750,000
Q1 2018 May 15, 2018	SELL	$40.1 - $52.45 $1.38 Million - $1.81 Million	-34,485 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$45.3 - $54.5 $84,575 - $101,751	1,867 Added 5.72%	34,485 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$48.1 - $52.15 $1.57 Million - $1.7 Million	32,618	32,618 $1.67 Million

274

44.3M

224K

35.7K

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.